Frontotemporal lobar degeneration

M Grossman, WW Seeley, AL Boxer, AE Hillis… - Nature Reviews …, 2023 - nature.com
… Bars show the relative frequency of the three most prevalent genetic forms of frontotemporal
degeneration across 22 countries/regions. Numbers shown in parentheses for each country/…

Incidence of syndromes associated with frontotemporal lobar degeneration in 9 European countries

G Logroscino, M Piccininni, C Graff, O Hardiman… - JAMA …, 2023 - jamanetwork.com
Importance Diagnostic incidence data for syndromes associated with frontotemporal lobar
degeneration (FTLD) in multinational studies are urgent in light of upcoming therapeutic …

[PDF][PDF] Frontotemporal lobar degeneration

D Neary, JS Snowden, L Gustafson, U Passant… - a consensus on clinical … - academia.edu
Article abstract-Objectiue: To improve clinical recognition and provide research diagnostic
criteria for three clinical syndromes associated with frontotemporal lobar degeneration. …

Deficient neurotransmitter systems and synaptic function in frontotemporal lobar degeneration—Insights into disease mechanisms and current therapeutic approaches

N Huber, S Korhonen, D Hoffmann, S Leskelä… - Molecular …, 2022 - nature.com
Frontotemporal lobar degeneration (FTLD) comprises a heterogenous group of fatal
neurodegenerative diseases and, to date, no validated diagnostic or prognostic biomarkers or …

Predictors of survival in frontotemporal lobar degeneration syndromes

S El-Wahsh, EC Finger, O Piguet, V Mok… - Journal of Neurology …, 2021 - jnnp.bmj.com
… clinical trials in patients diagnosed with frontotemporal lobar degeneration (FTLD) are now
… on disease survival across the syndromes of frontotemporal dementia, with comparison to …

Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration

EH Thijssen, R La Joie, A Wolf, A Strom, P Wang… - Nature medicine, 2020 - nature.com
… from other related dementias, such as frontotemporal lobar degeneration (FTLD), which can
… ), including approximately half of behavioral variant frontotemporal dementia (bvFTD), most …

Cerebrospinal fluid biomarkers in autopsy-confirmed Alzheimer disease and frontotemporal lobar degeneration

N Mattsson-Carlgren, LT Grinberg, A Boxer… - Neurology, 2022 - AAN Enterprises
… and an ultrasensitive Simoa assay for neurofilament light chain (NFL) correlate with
neuropathologic changes of Alzheimer disease (AD) and frontotemporal lobar degeneration (FTLD). …

Plasma neurofilament light for prediction of disease progression in familial frontotemporal lobar degeneration

JC Rojas, P Wang, AM Staffaroni, C Heller, Y Cobigo… - Neurology, 2021 - AAN Enterprises
Objective We tested the hypothesis that plasma neurofilament light chain (NfL) identifies
asymptomatic carriers of familial frontotemporal lobar degeneration (FTLD)–causing mutations …

TAF15 amyloid filaments in frontotemporal lobar degeneration

S Tetter, D Arseni, AG Murzin, Y Buhidma… - Nature, 2024 - nature.com
Frontotemporal lobar degeneration (FTLD) causes frontotemporal dementia (FTD), the most
common form of dementia after Alzheimer’s disease, and is often also associated with motor …

Plasma tau and neurofilament light in frontotemporal lobar degeneration and Alzheimer disease

I Illán-Gala, A Lleo, A Karydas, AM Staffaroni… - Neurology, 2021 - AAN Enterprises
Objective To test the hypothesis that plasma total tau (t-tau) and neurofilament light chain (NfL)
concentrations may have a differential role in the study of frontotemporal lobar